CD22 humanized monoclonal antibiotic

B beef play an important role in the pathogenesis of abounding autoimmune diseases. Altered approaches targeting the B corpuscle alcove are beneath investigation. Careful accentuation of B beef has been afresh accomplished application a humanised monoclonal antibiotic adjoin the B corpuscle apparent brand CD22. This antibiotic (epratuzumab) was originally developed for the analysis of non-Hodgkin's lymphoma and was begin to be effective, with a actual acceptable assurance profile. Recent studies accept accustomed the adeptness and assurance of epratuzumab in several autoimmune diseases, including systemic lupus erythematosus and primary Sjögren's syndrome.